It’s a bit ironic that the cheapest form of qPCR (SYBR green) shows this 16-32 fold variance in amplicon size alone.
Add in the RNA:DN/ hybrids and the qPCR the regulators are using could vary 1000 fold.
That’s exactly what Pharma wants.
An adjuvant you can modulate a 1000 fold and the FDA is too stupid to know it’s happening.